About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Patent Profile: Proteologics Announces Issuance of POSH siRNA Patent | Main | Seattle Genetics Earns Milestone Payment from Genentech for Initiation of Clinical Trial »

January 10, 2008

Celltrion and CSL to Collaborate

    By Jason Derry --

Celltrion_2 Celltrion, Inc. and CSL Limited have announced an agreement to develop and commercialize a monoclonal antibody for treating acute myeloid leukemia (AML).  The antibody, designated CSL 360, is currently in Phase 1 clinical trials in Australia.  CSL is a global, biopharmaceutical company located in Australia, having facilities throughout the world.  CSL focuses on developing protein-based medicines and vaccines.  Celltrion is a Korean Csl biopharmaceutical company that provides development and manufacturing services relative to biologics, such as recombinant proteins and antibodies.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 10:12 PM in Licensing |

Comments

The comments to this entry are closed.

May 2025

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Categories

Archives

More...